RxDoctor Payments Data

Ali Rahnama Vaghef, DPM

Foot & Ankle Surgery · Washington, DCNPI 1538588793

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $92,539 of the $132,053 with a category attached, or 70.1%. Orthofix Medical, Inc. accounts for 62.3% of it on its own, with 23 other manufacturers making up the rest. Among foot & ankle surgery clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$132,053in general payments, 2019–2025

Across 243 payments — averaging $543.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$82K
  • Arthrex$16K
  • Bone Support Inc.$9K
  • Ossio Inc$9K
  • Treace Medical Concepts, Inc.$8K
  • Supreme Orthopedic Systems, LLC$4K
  • plus $4K from 18 others

What the payments were for

  • Consulting fees$92,53970%
  • Speaking & faculty fees$11,5009%
  • Travel & lodging$10,7218%
  • Food & beverage$12,58010%
  • Education$4,7144%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$132,053 in reported general payments places this provider in the 90th percentile of 23 foot & ankle surgery providers in District of Columbia.

See all foot & ankle surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$155,915
Medicare patients
283
Services billed
686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium77$2,155
Ciclopirox17$774
Ammonium Lactate20$538
Ketoconazole16$200
Gabapentin11$176

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →